Statistics in Biopharmaceutical Research
Volume 15, 2023 - Issue 1
Special Section: A Collection of Articles on Opportunities and Challenges in Utilizing Real-World Data for Clinical Trials and Medical Product Development
Comment on “Biostatistical Considerations When Using RWD and RWE in Clinical Studies for Regulatory Purposes: A Landscape Assessment”
Yukari Uemuraa Department of Data Science, Center for Clinical Research, National Center for Global Health and Medicine, Tokyo, JapanCorrespondence[email protected]
https://orcid.org/0000-0002-3013-7775View further author information
https://orcid.org/0000-0002-3013-7775View further author information, , Shogo Nomurac Department of Biostatistics and Bioinformatics, The University of Tokyo, Tokyo, Japanhttps://orcid.org/0000-0001-8734-6984View further author information
https://orcid.org/0000-0001-8734-6984View further author information & 